To differentiate non-cardiogenic pulmonary edema from cardiogenic causes, there are a few areas that the CDI specialists and coders can look for in the documentation. Q: When is it appropriate to ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Pulmonary edema is a condition where fluid accumulates in the lungs. The lungs are organs of respiration. Oxygen from the air passes through small air sacs of the lungs called alveoli and oxygenates ...
This trial may be biased and lack generalizability for several reasons. First, sick patients, who required “lifesaving or emergency intervention” and might have benefited most, were excluded. Second, ...
Introduction In contrast to a series of recent meta‑analyses (MAs), the 3CPO (Three Interventions in Cardiogenic Pulmonary Oedema) randomized controlled trial (RCT) reported in 2008 did not find a ...
At normal doses, the drug's adverse effects are minimal, with the majority being attributed to acute withdrawal effects. A recent report published in the American Journal of Case Reports describes the ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The American College of Cardiology (ACC) has issued its first Concise Clinical Guidance (CCG) to create more streamlined and efficient processes to implement best practices in patient care. This CCG ...
The American College of Cardiology (ACC) has issued its first Concise Clinical Guidance (CCG) to create more streamlined and efficient processes to implement best practices in patient care. This CCG, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results